Login

Unlocking Nigerian Telecom Growth: Optiva's Role in Digital MVNO Success | Robert Stabile, CEO & Chairman of the Board at Optiva Inc 00:10:00

Share On Facebook Share On Twitter

Rob Stabile is Chairman/Interim CEO at Optiva Inc.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Maxime Brossard: From Finance to Family Business Leadership and Sustainability | Maxime Séché, Managing Director ,Seche Environnement SA.
00:10:00
Gino Roger Joins Midland Exploration Inc. | Gino Roger - President,CEO & Director of Midland Exploration Inc.
00:10:00
Mental Health in the Fast-Paced Financial Sector | Paul Feeney, CEO , Quilter Plc .
00:10:00
Maria Pope, President & CEO of Portland General Electric, shares insights on NYSE Floor Talk.
00:10:00
With a low cost base, a strong and experienced organisational culture, combined with a unique capital structure|PATRICK SCHORN , CHIEF EXECUTIVE OFFICER AT BorrDrilling
00:10:00
AAK AB Q1 2024 Interim Report: CEO Johan Westman’s Insights | Johan Westman, CEO , AAK AB.
00:10:00
ALWAYS BE THE TRACK IS THE RIGHT TALENT FOR LASTING SUCCESS|Scott Dinhofer, CEO,Weatherly Financial GroupLLC
00:10:00
Silver Market Analysis and Economic Impact of Energy Prices
00:10:00
Meredith Moore - Founder and Chief Strategist at Artisan Financial Strategies
00:10:00
Critical Resources Expands Mavis Lake Lithium Project
00:10:00
Børge Leknes Talks Insights and Transparency After Nord Insuretech's H1 2021 Report | Børge Leknes, CEO, Nord Insuretech Group AB.
00:10:00
Lexington Gold Set to List on London AIM Exchange After Reverse Takeover | Dr. Bernard Olivier, CEO , Lexington Gold Ltd.

© 2017 - Neuhu+